Episode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing

The Readout Loud - A podcast by STAT - Thursdays

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

Can Botox make Big Pharma attractive? What qualifies as a "cabal"? And will the CRISPR patent fight outlive us all?